机译:PF-06651600,双jak3 / tec家族激酶抑制剂
Pfizer Worldwide R&
D Med Design 610 Main St Cambridge MA 02139 USA;
Pfizer Worldwide R&
D Drug Safety R&
D 300 Technol Sq Cambridge MA 02139 USA;
Pfizer Worldwide R&
D Med Design 610 Main St Cambridge MA 02139 USA;
Pfizer Worldwide R&
D Inflammat &
Immunol 610 Main St Cambridge MA 02139 USA;
Pfizer Worldwide R&
D Inflammat &
Immunol 610 Main St Cambridge MA 02139 USA;
Pfizer Worldwide R&
D Integrat Biol 610 Main St Cambridge MA 02139 USA;
Pfizer Worldwide R&
D Med Design Eastern Point Rd Groton CT 06340 USA;
Pfizer Worldwide R&
D Med Design Eastern Point Rd Groton CT 06340 USA;
Pfizer Worldwide R&
D Med Design Eastern Point Rd Groton CT 06340 USA;
Pfizer Worldwide R&
D Med Design 610 Main St Cambridge MA 02139 USA;
Pfizer Worldwide R&
D Drug Safety R&
D Eastern Point Rd Groton CT 06340 USA;
Pfizer Worldwide R&
D Med Design 610 Main St Cambridge MA 02139 USA;
Pfizer Worldwide R&
D Inflammat &
Immunol 610 Main St Cambridge MA 02139 USA;
Pfizer Worldwide R&
D Inflammat &
Immunol 610 Main St Cambridge MA 02139 USA;
机译:PF-06651600,双jak3 / tec家族激酶抑制剂
机译:过程开发和扩展选择性JAK3共价抑制剂PF-06651600
机译:基于配体和E-Pharageophore建模,3D-QSAR和分层虚拟筛查,以鉴定脾酪氨酸激酶(SYK)和Janus激酶3的双重抑制剂(JAK3)
机译:用AEE788处理的结肠癌细胞的形态学分析,双酪氨酸激酶抑制剂和/或Celexoxib,COX-2特异性抑制剂 - 图像处理方法
机译:针对乳腺癌的双重激酶抑制剂的靶向设计。
机译:肾上腺素通过与JAK3激酶的ATP结合位点结合来选择性抑制JAK3信号传导
机译:Janus激酶3(JAK3)特异性抑制剂1((2S,5R)5 - ((7HPyrolo 2,3d嘧啶-4-基)氨基)-2-甲基哌啶-1-基)PROP-2-ZH -1-ONE(PF-06651600)允许在人类中询问JAK3信号